Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells
- 1 November 2000
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 7 (21), 1802-1809
- https://doi.org/10.1038/sj.gt.3301306
Abstract
The liver is an attractive target organ for insulin gene expression in type 1 diabetes as it contains appropriate cellular mechanisms of regulated gene expression in response to blood glucose and insulin. We hypothesize that insulin production regulated by both glucose and insulin may be achieved using the promoter of the glucose 6-phosphatase gene (G6Pase), the expression of which in the liver is induced by glucose and suppressed by insulin. Recombinant adenoviral vectors expressing the reporter gene CAT or insulin under transcriptional direction of the G6Pase promoter were constructed. Glucose-stimulated as well as self-limiting insulin production was achieved in vector-transduced hepatoma cells in which expression of the insulin gene was controlled by the G6Pase promoter. While insulin strongly inhibited the G6Pase promoter activity under low glucose conditions, its inhibitory capacity was attenuated when glucose levels were elevated. At the physiologic glucose level of 5.5 mM glucose, vector-transduced hepatoma cells produced a self-limited level of insulin at approximately 0.2-0.3 ng/ml, which is within the range of fasting levels of insulin in normal animals. These results indicate that the G6Pase promoter possesses desirable features and may be developed for regulated hepatic insulin gene expression in type 1 diabetes.Keywords
This publication has 37 references indexed in Scilit:
- Reversal of Diabetes in Mice by Implantation of Human Fibroblasts Genetically Engineered to Release Mature Human InsulinHuman Gene Therapy, 1999
- Insulin Production by Engineered Muscle CellsHuman Gene Therapy, 1999
- Regulated expression of mature human insulin in the liver of transgenic miceFEBS Letters, 1998
- Hepatic Insulin Gene Expression as Treatment for Type 1 Diabetes Mellitus in RatsMolecular Endocrinology, 1997
- Synthesis and Processing of Genetically Modified Human Proinsulin by Rat Myoblast Primary CulturesHuman Gene Therapy, 1996
- Gene therapy for diabetes mellitus in rats by hepatic expression of insulin.Proceedings of the National Academy of Sciences of the United States of America, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines.Endocrinology, 1993
- Recent Advances in Hepatic Glucose 6-Phosphatase Regulation and FunctionExperimental Biology and Medicine, 1993
- Effects of Hyperglycemia on Glucose Production and Utilization in Humans: Measurement With [23H]-, [33H]-, and [614C]GlucoseDiabetes, 1986